Cargando…
Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis
BACKGROUND: Prevalence of multidrug resistant tuberculosis (MDR-TB), defined as in vitro resistance to both rifampicin and isoniazid with or without resistance to other TB drugs, in sub-Saharan Africa (SSA) is reportedly low compared to other regions. These estimates are based on data reported to th...
Autores principales: | Lukoye, Deus, Ssengooba, Willy, Musisi, Kenneth, Kasule, George W, Cobelens, Frank G J, Joloba, Moses, Gomez, Gabriela B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412202/ https://www.ncbi.nlm.nih.gov/pubmed/25880829 http://dx.doi.org/10.1186/s12889-015-1614-8 |
Ejemplares similares
-
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2016) -
The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014) -
Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear-Positive Tuberculosis Patients in Uganda: Results of the First National Survey
por: Lukoye, Deus, et al.
Publicado: (2013) -
Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda
por: Kigozi, Edgar, et al.
Publicado: (2018) -
Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)